[go: up one dir, main page]

DK1093813T3 - Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk - Google Patents

Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk

Info

Publication number
DK1093813T3
DK1093813T3 DK00204182T DK00204182T DK1093813T3 DK 1093813 T3 DK1093813 T3 DK 1093813T3 DK 00204182 T DK00204182 T DK 00204182T DK 00204182 T DK00204182 T DK 00204182T DK 1093813 T3 DK1093813 T3 DK 1093813T3
Authority
DK
Denmark
Prior art keywords
coated
clavunalate
amoxycillin
film coating
polymeric film
Prior art date
Application number
DK00204182T
Other languages
Danish (da)
English (en)
Inventor
Creighton Pierce Conley
Nigel Philip Mccreath Davidson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1093813(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK1093813T3 publication Critical patent/DK1093813T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK00204182T 1994-04-23 1995-04-19 Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk DK1093813T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408117A GB9408117D0 (en) 1994-04-23 1994-04-23 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DK1093813T3 true DK1093813T3 (da) 2003-02-17

Family

ID=10754044

Family Applications (4)

Application Number Title Priority Date Filing Date
DK00204182T DK1093813T3 (da) 1994-04-23 1995-04-19 Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk
DK96202848T DK0761218T3 (da) 1994-04-23 1995-04-19 Fremgangsmåde til fremstilling af polymerovertrukne tabletter omfattende amoxycillin og clavulanat
DK95917937T DK0758235T3 (da) 1994-04-23 1995-04-19 Polymercoatet tablet omfattende amoxycillin og clavulanat
DK99200891T DK0978276T3 (da) 1994-04-23 1995-04-19 Polymerovertrukken tablet omfattende amoxycillin og clavulanat

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK96202848T DK0761218T3 (da) 1994-04-23 1995-04-19 Fremgangsmåde til fremstilling af polymerovertrukne tabletter omfattende amoxycillin og clavulanat
DK95917937T DK0758235T3 (da) 1994-04-23 1995-04-19 Polymercoatet tablet omfattende amoxycillin og clavulanat
DK99200891T DK0978276T3 (da) 1994-04-23 1995-04-19 Polymerovertrukken tablet omfattende amoxycillin og clavulanat

Country Status (35)

Country Link
US (1) US6051255A (hu)
EP (5) EP0758235B1 (hu)
JP (1) JP3622975B2 (hu)
CN (1) CN1134258C (hu)
AP (2) AP564A (hu)
AT (6) ATE223706T1 (hu)
AU (1) AU684949B2 (hu)
BG (1) BG62842B1 (hu)
BR (1) BR9507502A (hu)
CA (1) CA2188496A1 (hu)
CZ (2) CZ11376U1 (hu)
DE (5) DE69528204T2 (hu)
DK (4) DK1093813T3 (hu)
DZ (1) DZ1876A1 (hu)
ES (4) ES2182754T3 (hu)
FI (1) FI964249A0 (hu)
GB (1) GB9408117D0 (hu)
GR (2) GR3035031T3 (hu)
HK (5) HK1021860A1 (hu)
HU (1) HU228399B1 (hu)
IL (1) IL113433A (hu)
MA (1) MA23528A1 (hu)
MY (1) MY115351A (hu)
NO (1) NO310703B1 (hu)
NZ (1) NZ285080A (hu)
OA (1) OA10377A (hu)
PL (1) PL316966A1 (hu)
PT (4) PT758235E (hu)
RO (1) RO116997B1 (hu)
RU (1) RU2152213C1 (hu)
SA (1) SA95160343B1 (hu)
SI (1) SI0758235T1 (hu)
SK (1) SK282594B6 (hu)
WO (1) WO1995028927A1 (hu)
ZA (1) ZA953236B (hu)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
IL123563A (en) * 1995-09-07 2002-02-10 Smithkline Beecham Corp Pharmaceutical formulations comprising amoxycillin and clavulanate in a weight ratio between 14:1 and 16:1 inclusive
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
AU6496498A (en) * 1997-02-07 1998-08-26 Gist-Brocades B.V. Homogeneous granulated formulations for dose sipping technology
EA002595B1 (ru) * 1997-02-14 2002-06-27 Смитклайн Бичем Лаборатуар Фармасетик Фармацевтический препарат, содержащий амоксициллин и клавуланат, способ его приготовления и гранулят, содержащий амоксициллин и клавуланат
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
EP1023065A1 (en) * 1997-08-29 2000-08-02 Dsm N.V. Granules free of excipients
AU747099B2 (en) 1997-10-31 2002-05-09 Pharmacia Corporation Gellan gum tablet coating
MXPA01009808A (es) 1999-04-01 2002-04-24 Dsm Nv Aglomerados por cristalizacion.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
IE20000271A1 (en) * 1999-04-13 2001-04-04 Beecham Pharm Pte Ltd Pharmaceutical Formulations of Amoxycillin and Potassium Clavulanate
US20040038948A1 (en) * 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
EP1330236A2 (en) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) * 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
AU2003210925A1 (en) * 2002-02-07 2003-09-02 Rutgers, The State University Antibiotic polymers
KR100967782B1 (ko) * 2002-02-14 2010-07-05 글락소 그룹 리미티드 N-((1-N-부틸-4-피페리디닐)메틸)-3,4-디하이드로-2H-(1,3)옥사지노(3,2-a)인돌-10-카복스아미드 또는 그의 염을포함하는 제약 조성물, 및 건식 과립화를 포함하는 그의제조 방법
GB0203528D0 (en) * 2002-02-14 2002-04-03 Glaxo Group Ltd Process and composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
EP1648415A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533358C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648407A4 (en) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
US8758820B2 (en) * 2003-08-11 2014-06-24 Shionogi Inc. Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
EP1663169A4 (en) * 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
DE602005023965D1 (de) 2004-03-08 2010-11-18 Prosidion Ltd Pyrrolopyridin-2-carbonsäurehydrazide als inhibitoren von glykogenphosphorylase
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
JP5000491B2 (ja) 2005-05-20 2012-08-15 第一三共株式会社 フィルムコーティング製剤
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
SI2477611T1 (sl) * 2009-09-18 2017-07-31 Sanofi Formulacije tablete (Z)-2-ciano-3-hidroksi-but-2-enojska kislina-(4'-trifluormetilfenil)-amida z izboljšano stabilnostjo
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) * 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
IE20000271A1 (en) * 1999-04-13 2001-04-04 Beecham Pharm Pte Ltd Pharmaceutical Formulations of Amoxycillin and Potassium Clavulanate
EP1330236A2 (en) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin

Also Published As

Publication number Publication date
HK1027024A1 (en) 2001-01-05
EP1093813B1 (en) 2002-10-16
WO1995028927A1 (en) 1995-11-02
ES2180251T3 (es) 2003-02-01
AP9600868A0 (en) 1996-10-31
DE69521799T2 (de) 2002-06-13
ZA953236B (en) 1995-12-27
PT761218E (pt) 2001-03-30
RU2152213C1 (ru) 2000-07-10
ATE226074T1 (de) 2002-11-15
IL113433A (en) 2003-06-24
DE69528204D1 (de) 2002-10-17
PT978276E (pt) 2003-01-31
DK0978276T3 (da) 2003-01-20
AU2406895A (en) 1995-11-16
AT5350U1 (de) 2002-06-25
EP1243267A2 (en) 2002-09-25
BG62842B1 (bg) 2000-09-29
HUT76335A (en) 1997-08-28
DZ1876A1 (fr) 2002-02-17
DE29522153U1 (de) 2000-04-06
AU684949B2 (en) 1998-01-08
EP0978276A3 (en) 2000-04-12
EP1093813A3 (en) 2001-05-30
BR9507502A (pt) 1997-09-02
ATE203161T1 (de) 2001-08-15
CZ294168B6 (cs) 2004-10-13
FI964249L (fi) 1996-10-22
SI0758235T1 (en) 2001-10-31
NZ285080A (en) 1998-05-27
NO310703B1 (no) 2001-08-20
HU9602922D0 (en) 1996-12-30
JP3622975B2 (ja) 2005-02-23
HK1050992A1 (zh) 2003-07-18
EP1093813A2 (en) 2001-04-25
EP0761218B1 (en) 2000-10-11
DE69521799D1 (de) 2001-08-23
CN1134258C (zh) 2004-01-14
AT5349U1 (de) 2002-06-25
SA95160343B1 (ar) 2005-05-04
ATE196845T1 (de) 2000-10-15
PL316966A1 (en) 1997-03-03
HK1021860A1 (en) 2000-07-07
HK1009936A1 (en) 1999-06-11
EP0978276B1 (en) 2002-09-11
FI964249A0 (fi) 1996-10-22
DE69528608T2 (de) 2003-06-26
US6051255A (en) 2000-04-18
AP9500733A0 (en) 1995-04-30
PT1093813E (pt) 2003-02-28
AP564A (en) 1996-11-21
SK282594B6 (sk) 2002-10-08
IL113433A0 (en) 1995-07-31
CZ11376U1 (cs) 2001-07-12
DE69519093T2 (de) 2001-07-19
ES2152485T3 (es) 2001-02-01
EP0758235A1 (en) 1997-02-19
ES2161288T3 (es) 2001-12-01
HU228399B1 (en) 2013-03-28
DK0758235T3 (da) 2001-10-29
HK1036404A1 (en) 2002-01-04
CN1149829A (zh) 1997-05-14
OA10377A (en) 2001-11-21
DK0761218T3 (da) 2000-12-18
EP0761218A1 (en) 1997-03-12
BG100933A (en) 1997-07-31
GR3036844T3 (en) 2002-01-31
EP1243267A3 (en) 2002-10-30
CZ309096A3 (en) 1997-04-16
JPH09512027A (ja) 1997-12-02
DE69528608D1 (de) 2002-11-21
MA23528A1 (fr) 1995-12-31
PT758235E (pt) 2001-10-31
DE69528204T2 (de) 2003-08-07
NO964488L (no) 1996-12-17
DE69519093D1 (de) 2000-11-16
SK135496A3 (en) 1997-05-07
EP0758235B1 (en) 2001-07-18
ES2182754T3 (es) 2003-03-16
GR3035031T3 (en) 2001-03-30
EP0978276A2 (en) 2000-02-09
CA2188496A1 (en) 1995-11-02
ATE223706T1 (de) 2002-09-15
MY115351A (en) 2003-05-31
GB9408117D0 (en) 1994-06-15
RO116997B1 (ro) 2001-09-28
NO964488D0 (no) 1996-10-22

Similar Documents

Publication Publication Date Title
DK1093813T3 (da) Fremgangsmåde til at fremstille polymer-overtrukket tablet, der omfatter amoxycillin og clavunalat, belagt med et vandigt polymerfilmovertræk
DE69016433D1 (de) Beschichtungsverfahren und -vorrichtung.
NO894864L (no) Belagt forglasseringsmateriale og fremgangsmaate for belegging av dette.
IL104248A0 (en) Energy-polymerizable adhesive,coating,film and process for making the same
NO894865L (no) Belagt forglasseringsmateriale og fremgangsmaate for belegging derav.
NL1001008C2 (nl) Bekleed substraat en werkwijze voor de vorming ervan.
DE69621784D1 (de) Eingedrückte kernlose rollen und verfahren zu deren herstellung und benutzung
FI944171L (fi) Substraattien päällystykseen soveltuvia tahnoja, manetelmä niiden valmistamiseksi sekä niiden käyttö
DE69612216D1 (de) Metallblech mit rostpreventiver organischer beschichtung, verfahren zu dessen herstellung und behandlungsflüssigkeit dafür
KR970702757A (ko) 개선된 다이 립을 갖는 조합 롤 및 다이 피복 방법 및 장치(combination roll and die coating method and apparatus with improved die lip)
DE69506854D1 (de) Härtbare harzzusammensetzung, beschichtungszusammensetzung, beschichtungsmethode und beschichteter gegenstand
DK0633070T3 (da) Fremgangsmåde til pulvercoating til emner
DE69112222D1 (de) Beschichtungsverfahren.
FI960560L (fi) Menetelmä filminsiirtopäällystyksessä ja menetelmän toteuttamiseen tarkoitettu laitteisto
DE69618307D1 (de) Beschichtungsverfahren und - vorrichtung
DE69201489D1 (de) Beschichtungsverfahren.
DE69112487D1 (de) Beschichtungsapparat.
DE69521465D1 (de) Benzisoselen-azoline und-azine-derivate, verfahren zu deren herstellung und ihre therapeutische verwendung
AU8365891A (en) Method and apparatus for drying, curing and supporting a coated strand
IT9047538A0 (it) Prodotto rivestito e metodo per rivestirlo.
EE03248B1 (et) Hüdroksüpropüülmetüültselluloosi sisaldava kattega ranitidiinitablett ja nimetatud katte saamise protsess
UA1670S (uk) Прилад для нанесення фарбувальних, клейких, коректувальних та інших рідин
MX9205742A (es) Metodo y aparato para aplicar un revestimiento, auxiliado ultrasonicamente.
AU1861095A (en) Coating composition, process for forming cured film and coated article
KR950034041U (ko) U.v 도료층이 코팅된 전사지의 제조장치 및 u.v 도료층이 코팅된 전사지